Showing 1 - 10 of 643
Persistent link: https://www.econbiz.de/10001542582
Persistent link: https://www.econbiz.de/10001542301
Are breast cancer survival rates higher in the United States than in the United Kingdom and France? Are a patient's chances of dying within 30 days after admission to a hospital with a heart attack lower in Canada than in Korea? Are surgeons in some countries more likely to leave “foreign...
Persistent link: https://www.econbiz.de/10012442819
Persistent link: https://www.econbiz.de/10000024549
Persistent link: https://www.econbiz.de/10000980791
Persistent link: https://www.econbiz.de/10012443190
Persistent link: https://www.econbiz.de/10014002175
Persistent link: https://www.econbiz.de/10000886801
In recent years the scope for near perfect price discrimination, particularly in the digital economy, appears to have grown. This raises a question over how those jurisdictions in which exploitative price discrimination is an offence will respond. In contrast, the risk of price discrimination...
Persistent link: https://www.econbiz.de/10015081831
This paper explores excessive prices at the intersection between competition law and regulated sectors such as pharma. It was prepared as a background note for the OECD Competition Committee roundtable on “Excessive pricing in pharmaceuticals”, which took place in November 2018.
Persistent link: https://www.econbiz.de/10015082018